InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: ORBAPU post# 197371

Tuesday, 06/18/2019 2:46:38 PM

Tuesday, June 18, 2019 2:46:38 PM

Post# of 426014
They were FDA approved in 2014, had a bump above 20 than back to $7 in 2016 before they turned it around, extremely risky and even today with 1 billion in sales forecast in 2020 (similar to Amarin) they have a 15 billion market cap, so a BO at 15-20 Billion seems to cut off 5 years to get there based on that comparison.

There is no apple to apple comparisons to Amarin here.

Upside is higher GIA for sure
Downside is higher with GIA

Time value of money also a factor, you get $40 a share today or $40 a share in 2023, you can take your $40 a share today and get 3+ years to make more money with it.

There is risk in any stock reaching future revenue goals, Amarin is no different a BO takes risk completely off and at least doubles your money, you should see the appeal in that for many.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News